Birdwatch Archive

Birdwatch Note

2023-07-25 14:43:15 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

なぜブログにあるように”重症(Severe-adverse event) ”が262:150で接種群が多いのに当局が”副反応の疑いのある重篤な有害事象見られず”と承認したか(下記)というと https://www3.nhk.or.jp/news/html/20210212/k10012863501000.html 接種群で多い“severe event”は副反応ならgrade 3,発熱なら40度以下の副反応の事だからです(下記37P https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1112667/COVID-19_mRNA_Vaccine_BNT162b2__UKPAR___PFIZER_BIONTECH_ext_of_indication_11.6.2021.pdf 4000人のサブグループで8種の副反応でgrade 4は両群2名でした(上記37P なお盲検解除前に両群22000人中,非コロナ死亡がプラセボ12人、接種群14名との結果は接種群が偶然以上に多いという傾向すらありません(P=0.7) https://www.medcalc.org/calc/odds_ratio.php

Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1683085354679832577

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1683850404516462593
  • noteId - 1683850404516462593
  • participantId -
  • noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
  • createdAtMillis - 1690296195523
  • tweetId - 1683085354679832577
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 1
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • なぜブログにあるように”重症(Severe-adverse event) ”が262:150で接種群が多いのに当局が”副反応の疑いのある重篤な有害事象見られず”と承認したか(下記)というと https://www3.nhk.or.jp/news/html/20210212/k10012863501000.html 接種群で多い“severe event”は副反応ならgrade 3,発熱なら40度以下の副反応の事だからです(下記37P https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1112667/COVID-19_mRNA_Vaccine_BNT162b2__UKPAR___PFIZER_BIONTECH_ext_of_indication_11.6.2021.pdf 4000人のサブグループで8種の副反応でgrade 4は両群2名でした(上記37P なお盲検解除前に両群22000人中,非コロナ死亡がプラセボ12人、接種群14名との結果は接種群が偶然以上に多いという傾向すらありません(P=0.7) https://www.medcalc.org/calc/odds_ratio.php

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2023-07-25 14:43:15 UTC
(1690296195523)
1969-12-31 23:59:59 UTC
(-1)
2023-07-26 02:11:25 UTC
(1690337485071)
NEEDS_MORE_RATINGS 1969-12-31 23:59:59 UTC
(-1)

Note Ratings

rated at rated by
2023-07-25 18:48:29 -0500 Rating Details
2023-07-25 18:13:44 -0500 Rating Details
2023-07-25 18:05:49 -0500 Rating Details
2023-07-25 18:02:50 -0500 Rating Details
2023-07-25 17:54:02 -0500 Rating Details
2023-07-25 17:24:56 -0500 Rating Details
2023-07-25 17:09:30 -0500 Rating Details
2023-07-25 17:04:23 -0500 Rating Details
2023-07-25 17:04:05 -0500 Rating Details
2023-07-25 16:49:44 -0500 Rating Details
2023-07-25 16:38:07 -0500 Rating Details
2023-07-25 15:42:51 -0500 Rating Details
2023-07-25 12:14:52 -0500 Rating Details
2023-07-25 11:40:33 -0500 Rating Details
2023-07-25 11:18:46 -0500 Rating Details
2023-07-25 11:03:30 -0500 Rating Details
2023-07-25 10:29:23 -0500 Rating Details
2023-07-25 10:13:31 -0500 Rating Details
2023-07-25 10:11:34 -0500 Rating Details
2023-07-25 10:11:07 -0500 Rating Details
2023-07-25 10:08:54 -0500 Rating Details
2023-07-25 10:01:18 -0500 Rating Details
2023-07-25 10:00:13 -0500 Rating Details
2023-07-25 09:58:39 -0500 Rating Details
2023-07-25 09:54:51 -0500 Rating Details
2023-07-25 09:45:42 -0500 Rating Details
2023-07-26 10:48:12 -0500 Rating Details
2023-07-26 02:06:59 -0500 Rating Details
2023-07-26 01:58:09 -0500 Rating Details
2023-07-25 22:02:44 -0500 Rating Details
2023-07-28 08:55:44 -0500 Rating Details
2023-11-10 00:50:48 -0600 Rating Details